Ipca Labs

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE571A01038
NSEID: IPCALAB
BSEID: 524494

INR

1,330.25

36.7 (2.84%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 88.08 k

{
  "main_header": {
    "sid": 950228,
    "name": "Ipca Labs",
    "stock_name": "Ipca Labs",
    "full_name": "Ipca Laboratories Ltd",
    "name_url": "stocks-analysis/ipca-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,330.25",
    "chg": 36.7,
    "chgp": "2.84%",
    "dir": 1,
    "prev_price": "1,293.55",
    "mcapval": "33,749.00 Cr",
    "mcap": "Large Cap",
    "scripcode": "524494",
    "symbol": "IPCALAB",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE571A01038",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:03 AM",
    "bse_nse_vol": "88.08 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ipca-labs-950228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ipca Laboratories Outperforms Sector Amid Broader Market Volatility and Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-4-67-outperforming-pharmaceuticals-sector-on-april-3-2025-1693582",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/IpcaLaboratorie_priceRelatedfactors_883384.png",
        "date": "2025-04-03 09:35:24",
        "description": "Ipca Laboratories has demonstrated strong performance in the Pharmaceuticals & Drugs sector, gaining 4.67% on April 3, 2025, and achieving a cumulative increase of 5.24% over two days. The stock is currently above several key moving averages and has outperformed the Sensex over the past year."
      },
      {
        "title": "Ipca Laboratories Faces Trend Reversal Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-stock-declines-4-02-amid-broader-market-downturn-1659823",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/IpcaLaboratorie_priceRelatedfactors_851937.png",
        "date": "2025-04-01 11:40:34",
        "description": "Ipca Laboratories experienced a decline on April 1, 2025, following two days of gains, with the stock reaching an intraday low. Despite today's underperformance compared to its sector, the company has shown resilience over the past year and decade, significantly outperforming the Sensex in both periods."
      },
      {
        "title": "Ipca Laboratories Shows Resilience with Strong Stock Performance Amid Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-stock-gains-3-13-outperforms-sector-amid-market-decline-1646780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/IpcaLaboratorie_priceRelatedfactors_845973.png",
        "date": "2025-03-28 15:20:22",
        "description": "Ipca Laboratories has demonstrated strong performance in the Pharmaceuticals & Drugs sector, gaining 3.13% on March 28, 2025, despite a broader market decline. The stock has outperformed its sector and recorded a cumulative return of 4.15% over two days, reflecting resilience amid market fluctuations."
      },
      {
        "title": "Ipca Laboratories Faces Shift in Stock Outlook Amid Strong Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ipca-laboratories-stock-downgraded-to-hold-amid-technical-shift-and-stake-concerns-1598682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/IpcaLaboratorie_mojoScore_794788.png",
        "date": "2025-03-26 08:07:35",
        "description": "Ipca Laboratories has undergone a recent adjustment in its evaluation score, reflecting changes in stock technical trends. The company maintains a low Debt to Equity ratio and reported a 12.99% growth in net profit for the last quarter, alongside strong operational efficiency metrics. However, bearish signals in technical indicators and a slight reduction in promoter stake may indicate shifting confidence."
      },
      {
        "title": "Ipca Laboratories Experiences Mixed Technical Trends Amidst Market Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-technical-trend-shifts-from-mildly-bullish-to-mildly-bearish-amid-stock-price-decline-1598480",
        "imagepath": "",
        "date": "2025-03-26 08:04:03",
        "description": "Ipca Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting shifts in its technical indicators. The company's current stock price stands at 1447.75, slightly down from the previous close of 1457.10. Over the past year, Ipca has demonstrated a notable stock return of 20.91%, significantly outpacing the Sensex's return of 7.12% during the same period.\n\nIn terms of technical metrics, the MACD indicates a bearish trend on a weekly basis while remaining bullish monthly. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Bollinger Bands and moving averages suggest a mildly bearish outlook on a daily basis, while the KST reflects a bearish trend weekly but bullish monthly.\n\nIpca's performance over various time frames reveals a mixed picture. While the stock has seen a robust return of 121...."
      },
      {
        "title": "Ipca Laboratories Shows Resilience Amid Market Fluctuations and Premium Valuation",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-reports-20-91-annual-growth-outperforming-sensexs-7-12-gain-1591041",
        "imagepath": "",
        "date": "2025-03-25 18:00:15",
        "description": "Ipca Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has seen a notable performance shift today. The company's market capitalization stands at Rs 36,098.00 crore, categorizing it as a large-cap stock. Currently, Ipca Laboratories has a price-to-earnings (P/E) ratio of 50.00, which is above the industry average of 38.15, indicating a premium valuation relative to its peers.\n\nOver the past year, Ipca Laboratories has delivered a robust performance of 20.91%, significantly outperforming the Sensex, which recorded a gain of 7.12%. However, in the short term, the stock has experienced a decline of 0.64% today, contrasting with the Sensex's slight increase of 0.04%. \n\nIn terms of weekly performance, Ipca Laboratories has shown a gain of 6.85%, while its monthly performance reflects a modest increase of 2.35%. Despite a challenging three-month period with a decline of 8.50%, the stock has d..."
      },
      {
        "title": "Ipca Laboratories Faces Potential Trend Reversal Amid Recent Stock Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-stock-declines-3-19-after-six-days-of-gains-1579950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/IpcaLaboratorie_priceRelatedfactors_778171.png",
        "date": "2025-03-25 11:05:20",
        "description": "Ipca Laboratories, a key player in the pharmaceuticals sector, saw a decline on March 25, 2025, following a six-day gain streak. Despite this drop, the stock has shown resilience over the past week and has delivered strong returns over the last year, outperforming the broader market."
      },
      {
        "title": "Ipca Laboratories Outperforms Sector Amid Broader Market Gains and Positive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-3-29-outperforms-sector-amid-broader-market-surge-1575060",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/IpcaLaboratorie_priceRelatedfactors_772222.png",
        "date": "2025-03-24 14:20:23",
        "description": "Ipca Laboratories has demonstrated strong performance, gaining 3.29% on March 24, 2025, and achieving consecutive gains over six days, totaling 12.43%. The stock is currently above several moving averages and has outperformed the Sensex over the past year, highlighting its robust position in the pharmaceuticals sector."
      },
      {
        "title": "Ipca Laboratories Shows Strong Performance Amid Positive Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ipca-laboratories-gains-3-33-marking-fourth-consecutive-day-of-increases-1502395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/IpcaLaboratorie_priceRelatedfactors_731530.png",
        "date": "2025-03-20 11:50:20",
        "description": "Ipca Laboratories has experienced significant stock activity, gaining 3.33% on March 20, 2025, and outperforming its sector. The stock has shown a consistent upward trend over four days, with a total return of 8.09%. It reached an intraday high of Rs 1402.9 amid a positive broader market."
      }
    ],
    "total": 132,
    "sid": "950228",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/ipca-laboratories-950228"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2025",
      "details": "The Company has enclosed herewith certificate received from RTA under Reg74(5) SEBI DP Regulations 2018 for the quarter ended 31.03.2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "28-Mar-2025",
      "details": "Announcement under Reg 30 (LODR) - Acquisition",
      "source": "BSE"
    },
    {
      "caption": "Slump Sale Of Manufacturing Unit And Acquisition",
      "datetime": "28-Mar-2025",
      "details": "Slump Sale of Manufacturing Unit and Acquisition",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 27 Nov 24",
          "dt": "2024-11-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ipca Laboratories Ltd has announced <strong>1:2</strong> stock split, ex-date: 10 Jan 22",
          "dt": "2022-01-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ipca Laboratories Outperforms Sector Amid Broader Market Volatility and Mixed Signals

2025-04-03 09:35:24

Ipca Laboratories has demonstrated strong performance in the Pharmaceuticals & Drugs sector, gaining 4.67% on April 3, 2025, and achieving a cumulative increase of 5.24% over two days. The stock is currently above several key moving averages and has outperformed the Sensex over the past year.

Ipca Laboratories Faces Trend Reversal Amid Broader Market Decline

2025-04-01 11:40:34

Ipca Laboratories experienced a decline on April 1, 2025, following two days of gains, with the stock reaching an intraday low. Despite today's underperformance compared to its sector, the company has shown resilience over the past year and decade, significantly outperforming the Sensex in both periods.

Ipca Laboratories Shows Resilience with Strong Stock Performance Amid Market Decline

2025-03-28 15:20:22

Ipca Laboratories has demonstrated strong performance in the Pharmaceuticals & Drugs sector, gaining 3.13% on March 28, 2025, despite a broader market decline. The stock has outperformed its sector and recorded a cumulative return of 4.15% over two days, reflecting resilience amid market fluctuations.

Ipca Laboratories Faces Shift in Stock Outlook Amid Strong Financial Performance

2025-03-26 08:07:35

Ipca Laboratories has undergone a recent adjustment in its evaluation score, reflecting changes in stock technical trends. The company maintains a low Debt to Equity ratio and reported a 12.99% growth in net profit for the last quarter, alongside strong operational efficiency metrics. However, bearish signals in technical indicators and a slight reduction in promoter stake may indicate shifting confidence.

Ipca Laboratories Experiences Mixed Technical Trends Amidst Market Fluctuations

2025-03-26 08:04:03

Ipca Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting shifts in its technical indicators. The company's current stock price stands at 1447.75, slightly down from the previous close of 1457.10. Over the past year, Ipca has demonstrated a notable stock return of 20.91%, significantly outpacing the Sensex's return of 7.12% during the same period. In terms of technical metrics, the MACD indicates a bearish trend on a weekly basis while remaining bullish monthly. The Relative Strength Index (RSI) shows no significant signals for both weekly and monthly assessments. Bollinger Bands and moving averages suggest a mildly bearish outlook on a daily basis, while the KST reflects a bearish trend weekly but bullish monthly. Ipca's performance over various time frames reveals a mixed picture. While the stock has seen a robust return of 121....

Ipca Laboratories Shows Resilience Amid Market Fluctuations and Premium Valuation

2025-03-25 18:00:15

Ipca Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has seen a notable performance shift today. The company's market capitalization stands at Rs 36,098.00 crore, categorizing it as a large-cap stock. Currently, Ipca Laboratories has a price-to-earnings (P/E) ratio of 50.00, which is above the industry average of 38.15, indicating a premium valuation relative to its peers. Over the past year, Ipca Laboratories has delivered a robust performance of 20.91%, significantly outperforming the Sensex, which recorded a gain of 7.12%. However, in the short term, the stock has experienced a decline of 0.64% today, contrasting with the Sensex's slight increase of 0.04%. In terms of weekly performance, Ipca Laboratories has shown a gain of 6.85%, while its monthly performance reflects a modest increase of 2.35%. Despite a challenging three-month period with a decline of 8.50%, the stock has d...

Ipca Laboratories Faces Potential Trend Reversal Amid Recent Stock Volatility

2025-03-25 11:05:20

Ipca Laboratories, a key player in the pharmaceuticals sector, saw a decline on March 25, 2025, following a six-day gain streak. Despite this drop, the stock has shown resilience over the past week and has delivered strong returns over the last year, outperforming the broader market.

Ipca Laboratories Outperforms Sector Amid Broader Market Gains and Positive Momentum

2025-03-24 14:20:23

Ipca Laboratories has demonstrated strong performance, gaining 3.29% on March 24, 2025, and achieving consecutive gains over six days, totaling 12.43%. The stock is currently above several moving averages and has outperformed the Sensex over the past year, highlighting its robust position in the pharmaceuticals sector.

Ipca Laboratories Shows Strong Performance Amid Positive Market Trends

2025-03-20 11:50:20

Ipca Laboratories has experienced significant stock activity, gaining 3.33% on March 20, 2025, and outperforming its sector. The stock has shown a consistent upward trend over four days, with a total return of 8.09%. It reached an intraday high of Rs 1402.9 amid a positive broader market.